Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / FATE - Fate Therapeutics Q4 2021 Earnings Preview

FATE - Fate Therapeutics Q4 2021 Earnings Preview

Fate Therapeutics Inc.
Fate Therapeutics (NASDAQ:FATE) is scheduled to announce Q4 earnings results on Monday, Feb. 28, after market close. The consensus EPS estimate is -$0.66 and the consensus revenue estimate is $11.55M (-27.4% Y/Y). Over the last 1 year, FATE has beaten EPS estimates 25% of the time and has beaten revenue estimates 100% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Earlier this week, SA contributor Avisol Capital Partners wrote "Fate Therapeutics: Slowly Getting To An Attractive Position", rating the stock Hold.

For further details see:

Fate Therapeutics Q4 2021 Earnings Preview
Stock Information
Company Name: Fate Therapeutics Inc.
Stock Symbol: FATE
Market: NASDAQ
Website: fatetherapeutics.com
Menu
FATE FATE Quote FATE Short FATE News FATE Articles FATE Message Board
Get FATE Alerts

News, Short Squeeze, Breakout and More Instantly...